Objective: Preoperative endovascular embolization of intracranial tumors is performed to mitigate anticipated intraoperative blood loss. Although the usage of a wide array of embolic agents, particularly polyvinyl alcohol (PVA), has been described for a variety of tumors, literature detailing the efficacy, safety and complication rates for the usage of Onyx is relatively sparse. Materials and Methods We reviewed our single institutional experience with pre-surgical Onyx embolization of extra-axial tumors to evaluate its efficacy and safety and highlight nuances of individualized cases. Results: Five patients underwent pre-surgical Onyx embolization of large or giant extra-axial tumors within 24 hours of surgical resection. Four patients har...
BACKGROUND AND PURPOSE: Various techniques and materials have been used for the endovascular treatme...
BACKGROUND AND PURPOSE: Juvenile angiofibromas are hypervascular tumors that may benefit from preope...
Purpose: Onyx is an embolic agent currently FDA approved for neurointerventional procedures such as ...
SUMMARY: We report the first use of Onyx in the embolization of spinal tumors in 2 cases of aggressi...
Complete surgical resection of intra-axial hypervascular tumors located in the posterior fossa, in p...
BACKGROUND: Preoperative embolization has the potential to decrease intraoperative blood loss and fa...
Copyright: © 2015 Gonda DD, et al. This is an open-access article distributed under the terms of th...
SUMMARY: We report the feasibility and efficacy of percutaneous injection of Onyx (Micro Therapeu-ti...
BACKGROUND AND PURPOSE: Preoperative embolization facilitates the surgical management of com-plex ce...
BACKGROUND: The association of carotid body paragangliomas with neurovascular structures can cause c...
endovascularly in our department. They were 51 (54%) men and 43 (46%) women with a mean age of 32 ye...
Objective – to assess the safety and efficacy of Onyx embolization in the treatment of intracranial ...
International audienceBackground: Onyx® is a liquid embolic agent, which is approved for the treatme...
(AVMs) is increasingly used. However, it is still under discussion which embolic material is optimal...
Introduction: Embolisation has long been used as an adjunct to surgical resection in the treatment o...
BACKGROUND AND PURPOSE: Various techniques and materials have been used for the endovascular treatme...
BACKGROUND AND PURPOSE: Juvenile angiofibromas are hypervascular tumors that may benefit from preope...
Purpose: Onyx is an embolic agent currently FDA approved for neurointerventional procedures such as ...
SUMMARY: We report the first use of Onyx in the embolization of spinal tumors in 2 cases of aggressi...
Complete surgical resection of intra-axial hypervascular tumors located in the posterior fossa, in p...
BACKGROUND: Preoperative embolization has the potential to decrease intraoperative blood loss and fa...
Copyright: © 2015 Gonda DD, et al. This is an open-access article distributed under the terms of th...
SUMMARY: We report the feasibility and efficacy of percutaneous injection of Onyx (Micro Therapeu-ti...
BACKGROUND AND PURPOSE: Preoperative embolization facilitates the surgical management of com-plex ce...
BACKGROUND: The association of carotid body paragangliomas with neurovascular structures can cause c...
endovascularly in our department. They were 51 (54%) men and 43 (46%) women with a mean age of 32 ye...
Objective – to assess the safety and efficacy of Onyx embolization in the treatment of intracranial ...
International audienceBackground: Onyx® is a liquid embolic agent, which is approved for the treatme...
(AVMs) is increasingly used. However, it is still under discussion which embolic material is optimal...
Introduction: Embolisation has long been used as an adjunct to surgical resection in the treatment o...
BACKGROUND AND PURPOSE: Various techniques and materials have been used for the endovascular treatme...
BACKGROUND AND PURPOSE: Juvenile angiofibromas are hypervascular tumors that may benefit from preope...
Purpose: Onyx is an embolic agent currently FDA approved for neurointerventional procedures such as ...